0

Etidronate disodium hydrate

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATALP7414837
CAS7414-83-7 (anhydrous)
MDL NumberMFCD00152567
Molecular Weight249.99 (anhydrous basis)
EC Number231-025-7
InChI KeyGWBBVOVXJZATQQ-UHFFFAOYSA-L
Description≥97% (NMR), solid
SolubilityH2O: ≥10 mg/mL
Assay≥97% (NMR)
Colorwhite
Formsolid
MP>300 °C
Size10MG, 100MG
Storage Conditions2-8°C
1

A Review of Minodronic Acid Hydrate for the Treatment of Osteoporosis

Shinji Tanishima, Yasuo Morio

Clin Interv Aging. 2013;8:185-9.

PMID: 23440003

1

Comparative Study of Pamidronate Disodium and Etidronate Disodium in the Treatment of Cancer-Related Hypercalcemia

R Gucalp, P Ritch, P H Wiernik, P R Sarma, A Keller, S P Richman, K Tauer, J Neidhart, L E Mallette, R Siegel

J Clin Oncol. 1992 Jan;10(1):134-42.

PMID: 1727915

1

Conventional Treatment of Hypercalcemia of Malignancy

T G Davidson

Am J Health Syst Pharm. 2001 Nov 15;58 Suppl 3:S8-15.

PMID: 11757206

1

Crystallization and Preliminary Neutron Diffraction Experiment of Human Farnesyl Pyrophosphate Synthase Complexed With Risedronate

Takeshi Yokoyama, Andreas Ostermann, Mineyuki Mizuguchi, Nobuo Niimura, Tobias E Schrader, Ichiro Tanaka

Acta Crystallogr F Struct Biol Commun. 2014 Apr;70(Pt 4):470-2.

PMID: 24699741

1

Preparation, Characterization, Release Kinetics, and in Vitro Cytotoxicity of Calcium Silicate Cement as a Risedronate Delivery System

Tianxing Gong, Zhiqin Wang, Yubiao Zhang, Changshan Sun, Quanzu Yang, Tom Troczynski, Urs O Häfeli

J Biomed Mater Res A. 2014 Jul;102(7):2295-304.

PMID: 23946228

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode